Evidence Against a Bacterial Endotoxin Masking Effect in Biologic Drug Products by Limulus Amebocyte Lysate Detection

References

1. 1.↵
   Chapter <85> Bacterial Endotoxins Test. In United States Pharmacopeia; United States Pharmacopeial Convention: Rockville, MD, 2013.
2. 2.↵
   Chapter 2.6.14 Bacterial Endotoxins. In European Pharmacopoeia; The European Directorate for the Quality of Medicines & Health Care: Strasbourg, France, 2014.
3. 3.↵
   Chapter 4.01 Bacterial Endotoxins Test. In Japanese Pharmacopoeia; Japanese Ministry of Health, Labour and Welfare: Tokyo, Japan, 2011.
4. 4.↵
   U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry—Pyrogen and Endotoxin Testing: Questions and Answers, June 2012.
5. 5.↵
   1. Chen J.

   Low Endotoxin Recovery in Common Biologic Products. Presented at PDA 8th Annual Global Conference on Pharmaceutical Microbiology, Bethesda, MD, 2013.
6. 6.
   1. Bowers K.,
   2. Tran L.

   Creation of an in-house naturally occurring endotoxin preparation for use in endotoxin spiking studies and LAL sample hold time analysis. Am. Pharm. Rev. 2011, 14 (6).
7. 7.↵
   1. Williams K.

   Endotoxin test concerns of biologics. Am. Pharm. Rev. 2013, 16 (6).
8. 8.↵
   1. McCullough K.

   The Bacterial Endotoxins Test: A Practical Guide. PDA and Davis Healthcare International Publishing, LLC: River Grove, IL, 2011; pp 48–49.